Citations

Citations to this article as recorded by  

• Nucleotide metabolism-associated drug resistance gene NDUFA4L2 promotes colon cancer progression and 5-FU resistance
  Hongxin HE, Shiyao ZHENG, Shangkun JIN, Weijie HUANG, Enhao WEI, Shen GUAN, Chunkang YANG
  Scientific Reports.2025;[Epub]     CrossRef
• Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer
  Dorothy Bhattacharjya, Nageswaran Sivalingam
  Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(11): 8445.     CrossRef
• The combination of SHP099 inhibits the malignant biological behavior of L-OHP/5-FU-resistant colorectal cancer cells by regulating energy metabolism reprogramming
  Meilian Wang, Kun Yu, Wen Fu, Lihong Yang
  Biochemical and Biophysical Research Communications.2024; 728: 150262.     CrossRef
• Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma
  Shin Tojo, Koh‐ichi Nakashiro, Nobuyuki Kuribayashi, Daisuke Uchida
  Cancer Medicine.2024;[Epub]     CrossRef
• The potential of kaempferol in digestive system tumors: recent advances and mechanistic insights
  Xunxing Hao, Meng Ding, Chenyu Chi, Xiaodong Xu, Xiaoyu Zhang, Mingzhe Hu
  Discover Oncology.2024;[Epub]     CrossRef
• Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses
  Jiazheng Li, Chao Yang, Yongbin Zheng
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer
  Cairu Gu, Xifeng Xiong, Wei Liu, Elisa Belluzzi
  Disease Markers.2023; 2023: 1.     CrossRef
• TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer
  Yaoqing Li, Chuchu Xu, Renjun Zhu, Liyijing Shen, Gengyuan Hu, Kelong Tao, Feng Tao, Zengxin Lu, Guolin Zhang
  Journal of Cancer Research and Clinical Oncology.2023; 149(10): 7235.     CrossRef
• Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
  Katharine Yu, Amrita Basu, Christina Yau, Denise M. Wolf, Hani Goodarzi, Sourav Bandyopadhyay, James E. Korkola, Gillian L. Hirst, Smita Asare, Angela DeMichele, Nola Hylton, Douglas Yee, Laura Esserman, Laura van ‘t Veer, Marina Sirota
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis
  Beatriz Andrea Otálora-Otálora, Juan Javier López-Rivera, Claudia Aristizábal-Guzmán, Mario Arturo Isaza-Ruget, Carlos Arturo Álvarez-Moreno
  International Journal of Molecular Sciences.2023; 24(23): 16638.     CrossRef
• Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and in vitro experiments
  Hu Chen, Junsei Sameshima, Shiho Yokomizo, Tomoki Sueyoshi, Haruki Nagano, Yuka Miyahara, Taiki Sakamoto, Shinsuke Fujii, Tamotsu Kiyoshima, Thomas Guy, Seiji Nakamura, Masafumi Moriyama, Naoki Kaneko, Shintaro Kawano
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data
  Hamed Manoochehri, Akram Jalali, Hamid Tanzadehpanah, Amir Taherkhani, Massoud Saidijam
  Journal of Gastrointestinal Cancer.2022; 53(3): 649.     CrossRef
• Exosomes-mediated tumor treatment: One body plays multiple roles
  Na Xu, Ranran Guo, Xiaotong Yang, Ning Li, Jia Yu, Peng Zhang
  Asian Journal of Pharmaceutical Sciences.2022; 17(3): 385.     CrossRef
• Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
  Ching-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, Guan-Sian Low, Ping-Yun Ou, Chiun Hsu, Da-Liang Ou
  Cancers.2022; 14(2): 294.     CrossRef
• Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma
  Xiaonan Zhou, Shizhu Guo, Yonghong Shi
  Scientific Reports.2022;[Epub]     CrossRef
• Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis
  Haili Wu, Jin’e Du, Chenglu Li, Hanqing Li, Huiqin Guo, Zhuoyu Li
  International Journal of Molecular Sciences.2022; 23(7): 3544.     CrossRef
• Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact
  Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, Sara Seriah, Mohammad Naseem Siddiqui, Shoib Sarwar Siddiqui
  Seminars in Cancer Biology.2022; 86: 436.     CrossRef
• Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma
  Dachen Bian, Yanhua Chen, Ahmed Faeq Hussein
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
  Qian Zou, Xue Lei, Aijing Xu, Ziqi Li, Qinglian He, Xiujuan Huang, Guangxian Xu, Faqing Tian, Yuanlin Ding, Wei Zhu
  Frontiers in Immunology.2022;[Epub]     CrossRef
• CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer
  Binhan Wang, Manni Wang, Danyi Ao, Xiawei Wei
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2022; 1877(5): 188799.     CrossRef
• A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer
  Xu Wang, Yuanmin Xu, Longfei Dai, Zhen Yu, Ming Wang, Shixin Chan, Rui Sun, Qijun Han, Jiajie Chen, Xiaomin Zuo, Zhenglin Wang, Xianyu Hu, Yang Yang, Hu Zhao, Kongwang Hu, Huabing Zhang, Wei Chen
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer
  Mengyu Sun, Xiaoyu Ji, Meng Xie, Xiaoping Chen, Bixiang Zhang, Xiangyuan Luo, Yangyang Feng, Danfei Liu, Yijun Wang, Yiwei Li, Bifeng Liu, Limin Xia, Wenjie Huang
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment
  Shamin Azwar, Heng Fong Seow, Maha Abdullah, Mohd Faisal Jabar, Norhafizah Mohtarrudin
  Biology.2021; 10(9): 854.     CrossRef
• CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
  Sipei Nie, Yicong Wan, Hui Wang, Jinhui Liu, Jing Yang, Rui Sun, Huangyang Meng, Xiaolin Ma, Yi Jiang, Wenjun Cheng
  Journal of Ovarian Research.2021;[Epub]     CrossRef
• The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy
  Zeyu Wang, Yuze Liu, Yuyao Mo, Hao Zhang, Ziyu Dai, Xun Zhang, Weijie Ye, Hui Cao, Zhixiong Liu, Quan Cheng
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression
  Louis Boafo Kwantwi, Shujing Wang, Youjing Sheng, Qiang Wu
  Bioengineered.2021; 12(1): 6923.     CrossRef
• CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities
  San-Hui Gao, Sheng-Zhi Liu, Gui-Zhen Wang, Guang-Biao Zhou
  Life.2021; 11(12): 1282.     CrossRef
• Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment
  Margarita Neganova, Junqi Liu, Yulia Aleksandrova, Sergey Klochkov, Ruitai Fan
  Cancers.2021; 13(23): 6062.     CrossRef
• Chemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy
  Klara Mladenić , Mirela Sedić
  Clinical Cancer Drugs.2021; 8(2): 67.     CrossRef